Gf Fund Management Co. Ltd. Aclaris Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.85 Trillion
- Q4 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,128 shares of ACRS stock, worth $5,362. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,128Holding current value
$5,362% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACRS
# of Institutions
107Shares Held
81.7MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN14.3MShares$35.9 Million24.79% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$22.4 Million2.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.52MShares$16.4 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.28MShares$13.3 Million0.02% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.61MShares$11.6 Million0.59% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $168M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...